Brochure

5th annual
Sign up before 31 December 2011 and save up to SGD1600
Bio ASIA
CONVENTION 2012
19 22 March, 2012 Marina Bay Sands, Singapore
Held together with:
Life
Where the future of the Asian and global biopharmaceutical market is shaped
Access the most inuential decision makers in Asias biopharma industry Forge strategic partnerships with Asias up-and-coming innovators Network with more than 4,000 key stakeholders from over 30 countries
Organised by:
www.terrapinn.com/biopharma
Your gateway to Asias biop

BioPharma Asia Convention is the largest and most inuential event in the region that brings together more than 4,000 global and Asian biopharmaceutical stakeholders to discuss strategy, investment, innovation and partnerships.
The most impressive thing about the convention is its ability to bring together different industrial players in Asia not only large pharmas, biotechs, government agencies and the public sector as well as academics. It has presented an excellent occasion for us to network and nd new collaboration opportunities with our industrial partners.
Lim Chuan Poh, Chairman, Agency for Science, Technology and Research, (A*STAR), Singapore
Establish thought leadership in front of a pre-qualied audience
BioPharma Asia Convention 2012 is the only event in the region that will show you:
How to identify emerging rst-mover opportunities in Asia How to expand to untapped or newly established markets How to access funding and investment into new Asian drug developments How to increase operational and manufacturing efciency and achieve signicant cost savings How to maximise your return on investment with each new development project
Why you need to be at BioPharma Asia Convention 2012

This is the only event that covers the entire value chain of the pharma industry There is no other event in Asia that can bring you the most important and inuential decision makers in the regions pharma industry It will host 9 conferences, 200 speakers, 100+ exhibitors, 10 country pavilions, 100 poster presentations and 4,000 attendees Over 100 Asian biotechs are ready to show off their hottest innovations
Engage and build rapport with new prospects
Meet face to face with senior level decision makers
What to expect in
2012
BioPharma Asia Convention is Asias best attended and biggest biopharmaceutical event:
4000 500 200 100 66 50 9 1
attendees exhibitor products speakers poster presentations on-oor seminar sessions networking hours conferences event
Send 3 delegates and get 1 free delegate pass. Contact Huisan at +65 6322 2770 or huisan.soh@terrapinn.com & quote KQVQ*
Share industry opportunities with business partners
*offer ends 16 Dec 2011
BOOK NOW! online www.terrapinn.com/biopharma | email huisan.soh@terrapinn.com | phone +65 6322 2770 | fax +65 6223 3554
harmaceutical industry
Key speakers
Andreas Busch Member of the Bayer HealthCare Executive Committee and Head of Global Drug Discovery, Bayer HealthCare, Germany
Andreas has been a member of the Bayer HealthCare Executive Committee as Head of Pharmaceuticals Research since February 2007. He has also been in charge of Research in the Animal Health Division since March 2011. Andreas has worked at various research institutes in Germany and USA. prior to joining the industry. His scientic work has been recognised with the Franz Volhard and a Sir Bernhard Katz Awards. At this conference, Andreas will share his views on partnerships and collaborations with biotechs and research institutes. Find out how such an alliance can foster innovation and transformation in the biopharma industry.
Anand Tharmaratnam Senior Vice President and Head of Asia Markets, Clinical Development, Quintiles, Singapore
Anand is responsible for the Quintiles clinical development business across the Asia Pacic region, including Japan. He has built a wealth of industry experience he was tasked with setting up the Quintiles ECG Lab in Mumbai, India in 2001; the rst global ECG lab outside of Europe or the USA. Anand was also instrumental in setting up international alliances for the business in Hawaii, Brazil and Peru. He had held numerous positions at Quintiles, and this includes the appointment of Medical Director for Quintiles Europe as well as Chief Executive Ofcer of Quintiles Southeast Asia, Taiwan and Korea. At this conference, Anand will share his opinions on the growth opportunities in Asia for the biopharmaceutical industry and relate his experiences on strategic business partnership models that can help fuel this growth.
Chihiro Yokota Corporate Executive, Global Head of Business Development/Licensing & Alliances, Astellas Pharma, Japan
Chihiro has more than 30 years of pharmaceutical industry experience and is a highly regarded individual of the industry. He has led the companys global business expansion and managed several deals including the acquisition of OSI Pharmaceuticals and alliances with Ambit Biosciences and Medivation. Prior to his current position, Chihiro served as Global Head of Project Management at Astellas Pharma Global Development. He also previously held the position of Vice President of Clinical Research at Fujisawa Research Institute of America. With his vast experience in the pharmaceutical industry, Chihiro will be sharing his views on how Asia can be capitalised as a source of growth and innovation for pharmas to strengthen their drug development pipelines.
Saloman Azoulay Senior Vice President, Medical and Development, Emerging Markets/ Established Products Business Units, Pzer, USA
Saloman has accumulated a wealth of experience on developing businesses and partnerships in emerging markets like Russia, China and India. He was appointed to lead the development organisation in Tokyo in 2006 where he supervised more than 400 colleagues and was accountable for a number of drug approvals and regulatory submissions. Saloman has led the team for the ling of the varenicline (Champix) smoking cessation programme in the USA. and EU in 2003, where he successfully received a priority review by the U.S. FDA (with a review period of 6 months) due to its demonstrated effectiveness in clinical trials. At this conference, Saloman will be relating his experiences in adopting strategic business models for the emerging markets with a focus on business development and partnership opportunities in Asian powerhouses China and India.
Outstanding speaker
World class speakers from global pharmas
Anders Ekblom Executive Vice President, Global Medicines Development AstraZeneca, Sweden Jeffrey Kasher Vice President & Chief Operating Ofcer, Global Clinical Development Eli Lilly, USA
Key investors in Asias pharma industry

Lu Hong Bo Executive Director for Asia Orbimed, China
Helmut Haning Senior Vice President, Head Global Innovation Sourcing, Bayer HealthCare, Germany
Ceri Davies Vice President, GSK Singapore R&D Site, Head of Neural Pathways DPU GlaxoSmithKline, Singapore
Carrie Hillyard Director CM Capital Investments, Australia
Yuan Xu Vice President and Head of Biotherapeutics Novartis, USA
Esther Alegria, Vice President, Manufacturing, Biogen Idec, Denmark
John Diekman Founder and Managing Partner 5AM Ventures, USA
Tony DAmore Vice President, Process Development Sano Pasteur, Canada
Christopher Fang Worldwide Director, Clinical Research & Medical Affairs, DePuy Spine, Johnson & Johnson, USA Pierre Nader Director, Operational Improvement Excellence Pzer, UK
Alfred Scheidegger Founding Partner & Chief Executive Ofcer Nextech Invest, Switzerland
Kunal Jaiswal Director, Global Clinical Supply Planning Merck, USA
Goro Takeda Venture Partner Sonnova Ventures, Japan
Hear from more than 120

Pharma Partnering & Investment World Asia 2012
Deanna M. Petersen, Vice President, Business Development, Shire Human Genetic Therapies, USA Hemant Pachnanda, Director of Strategy and Business Development, Sano-Aventis, Singapore Harvinder Popli, Director, Licensing, Ranbaxy, India Anand Gautam, Director, Biopharmaceutical Sourcing, Novo Nordisk, Denmark Donald Rindell, Director, Amylin, USA Ravi Sodha, Senior Director, Business Development, Acetelion, Switzerland Aditya Kapil, Principal, VenturEast, India Ma Hui Hsing, Venture Partner, TVM Capital, Germany Dato Nazlee Kamal, CEO, Malaysian Biotechnology Corporation, Malaysia William Hu, Partner, Qiming Venture Partners, China A. Sinclair Dunlop, Managing Partner, Rock Spring Ventures, USA Alvin Luk, Senior Director, Global Clinical Affairs and Operations, Biogen Idec Hemophilia, USA Vivek Kadambi, Senior Director and Head, Drug Safety Evaluation, Millennium: The Takeda Oncology Company, USA Krisztina Nemenyi, Group Director, Asia Pacic, International Global Regulatory Sciences, Bristol-Myers Squibb, South Korea Patrecia Valone, Director, Development Operations, Takeda Global Research & Development Center (Asia), Singapore Tetsuomi Takano, Senior Director and Head, Asian Project Management, Asian Development, Astellas Pharma, Japan Haiyan Jiang, Director, Preclinical and Clinical Research, Biogen Idec Hemophilia, USA Michael DuVall, Associate Director, Toxicology, Abbott, USA Wouter Schul, Associate Director, Preclinical Development and Portfolio Management, Novartis Institute for Tropical Diseases, Singapore Yan Li, Head, Clinical Development, Oncology, Infectious Disease, Respiratory and Immunology, Emerging Markets, Merck, USA Shashidhar Rao, Head, Global Medical Affairs, India Operations, Novartis, India Trang Nguyen Hoang Hanh, Head, Medical Affairs and Clinical Operations, Sano-Aventis, Vietnam Larry Ajuwon, Senior Outsourcing, Genzyme, The Netherlands Young-ok Kim, Director, Clinical Trials Regulation, Korea Food and Drug Administration, South Korea Joseph Scheeren, Senior Vice President and Head, Global Regulatory Affairs, Bayer Healthcare, USA Helen Han Hsu, Vice President and Head, Global Preclinical Development, Asia Pacic & Global Business Development, Johnson & Johnson, China
Biologic Manufacturing World Asia 2012

David Shen, Vice President and Global Head, Biologics Research and Early Development, Teva Pharmaceuticals, USA Uwe Buecheler, Senior Vice President, Biopharmaceutical Division, Boehringer Ingelheim Pharma, Germany Wassim Nashabeh, Global Head, Technical Regulatory Policy & Strategy, Genentech, USA Wu Ke, President & Founder, BravoBio, China Chandrakant Kathote, Senior Director, Manufacturing, Fermentation Derived Products, Biocon, India Jason Li, Director, Downstream Processing, Genor BioPharma, China Batrice Serckx, Associate Director, Local Manufacturing and CMO Governance, UCB Pharma, Belgium Bernhard Helk, Global Executive Director, Technical Development, Novartis, Switzerland
Pharma Trials World Asia 2012

Seong-Choon Choe, Senior Vice President, Chief Medical Ofcer, Hanall Biopharma, South Korea Kezhou Zhang, Vice President and Medical Director, Novo Nordisk (China) Pharmaceuticals, China Qayum Mukaddam, Vice President, Medical Services, Abbott, India Thomas Singer, Global Head, Non-Clinical Safety, F. Hoffmann-La Roche, Switzerland
line up
Leading Asian pharmas
Stewart Geary Vice President, Deputy Director, Corporate Regulatory Compliance and Quality Assurance Eisai, Japan Sampad Bhattacharya Vice President Operations Sun Pharmaceutical Industries, India
I have not seen such a big audience before at an industrial conference so congratulations to the organizers for being able to attract such a good prole of attendees at the event. Julius Vaz, Senior Vice President, Global Medical Affairs, Dr Reddys, India
Emerging biotechs in Asia

Kiran Mazumdar Shaw, Chairman & Managing Director, Biocon, India
Industry thought leaders in Asia

Paul Bolno Vice President, Head of Asia, WWBD GlaxoSmithKline, China Werner Katzmann Senior Director, Regional Medical Affairs, Asia Pacic Biogen Idec, Singapore
Hua Mu Senior Vice President, Clinical Research & Development Hutchinson MediPharma, China
Shivraj Dasari, Vice President Inno Bioventures, Malaysia
Rikrik Ilyas Managing Director Innogene, Singapore
Pankaj Monga, Director Brand Protection of Asia, Johnson & Johnson, India
Ken Araki Senior Director of Corporate Strategy & Planning Takeda Pharmaceutical, Japan
Shermal Perera Managing Director Siogen, Malaysia
Cristina Chang Medical Director, Taiwan and Korea Abbott, Taiwan
Rakesh Kumar Director, Vaccine Production Serum Institute of India, India
Bob Elliot Emeritus Professor and Medical Director Living Cell Technologies, New Zealand
Michel Liuzzi Director, Early Discovery Program Institut Pasteur, Korea
global and regional leaders

Jacks Lee, Senior Vice President, Vaccines, Pharmaceuticals & sterile operations, Merck sharp & Dohme, USA Mahbubur Rahman, Deputy Director, Analytical Biochemistry, Analytical Process & Technology, Industrial Operations, Sano Pasteur, USA Berthold Boedeker, Head of Cell Culture and Pilot Plants, Global Drug Discovery & Biotech Development, Bayer Schering Pharma, Germany Christian Leist, Head of Bioprocess Development Group, Novartis, Switzerland Ulrich Rmenapp, Contract Manufacturing Biotech, Head Biotech Projects, Bayer Schering Pharma AG, Germany Klaus Kaiser, Head GMP Purication Global/ Global Biological Development, Bayer Healthcare LLC, Germany Torres Victor, MBB, Lean Deployment Division Leader, Baxter Bioscience, France University of Singapore, Singapore Chih-Liang Chin, Director & Section Head, Translational Medicine Research Centre, MSD, Singapore Alex Matter, CEO, Experimental Therapeutics Centre, A*Star, Singapore Martin Everett, Head of Research, MerLion Pharmaceutical, Singapore Swaine Chen, Senior Investigator, Genome Institute of Singapore, A*Star, Singapore Adam Gehring, Assistant Principal Investigator, Singapore Institute for Clinical Sciences, A*Star, Singapore
Drug Discovery World Asia 2012

Lihu Yang, Director, Medicinal Chemistry, Worldwide External Basic Research, Merck, USA Guoxin Zhu, Senior Director, Eli Lilly, USA Hans-Joachim Boehm, Global Head, Chemistry, Roche, Switzerland Sreehari Babu, Head, Chemical & Pharmaceutical Proling, Novartis, China Koteppa Pari, Senior Group Leader & Head, Discovery Analytical Sciences, Piramal Life Sciences, Piramal Healthcare, India Iman El-Hariry, Vice President, Clinical Research, Synta Pharmaceuticals, USA Olivier Heudi, Head, Translational Sciences, Novartis, Switzerland Juergen Engel, CEO & President, AEterna Zentaris, Germany David Wadsworth, Global Head, Outsourcing & Operations, Roche, Switzerland Atsushi Nagahisa, President & CEO, RaQualia, Japan Shinichi Koizumi, CSO, RaQualia, Japan Kevin Tan, Scientic Director, Biolynx Technologies, Assistant Professor, Department of Microbiology, National
Pharma & Biotech Supply Chain World Asia 2012

Joachim Kuhn, CEO, Va-Q-Tec, Germany Michael Lee, VP, Manufacturing, Biomabs Pharmaceuticals, China Frank Binder, Senior Director, International Logistics & Supply Chain, Celgene, Switzerland Sam Zhou, Head, Security for Asia Region, Sano-Aventis, China Kalyana Krishnan, Head, Global Supply Chain, Ranbaxy Laboratories, India Prashant Sharma, Head, Supply Chain, Zydus Cadila, India Melchizedek Camus, Contractor Relations Lead, Asia Pacic, Pzer Consumer Healthcare, Philippines Neeraj Bhargava, Director, Regional Logistics, Procurement, Johnson & Johnson, Singapore
Pharma Manufacturing World Asia 2012

Greg Guyer, Senior Vice President, Global Quality, Merck, USA Vinay Nayak, President, Alembic Pharmaceuticals Limited, India Thomas Steckenreiter, Marketing Director, Endress+Hauser Conducta, Germany Ben Chen, VP, Formosa Laboratories, Taiwan Christian Houborg, VP, Service & Technical Operations and Lean, LundBeck, Denmark Flemming Simonsen, Senior Director, Global Quality Assurance, Quality System & Tools, Ferring International Center SA, Switzerland Kim Sandell, Director, Operations Management & Operational Excellence, Pzer, Sweden
Customise your learning ex

9 Conferences
A strategic conference that brings together stakeholders of the global and Asian biologic manufacturing sector to discuss best practices in optimizing production efciency and achieving operational excellence.
Gain exclusive insights from thought leaders
A strategic conference where senior level executives of the global and Asian clinical trial sector discuss strategies to accelerate clinical development and enhance clinical operations through effective offshoring and outsourcing options in Asia.
A strategic platform where key stakeholders and decision makers of the industry discuss about licensing, investment and partnership opportunities and identify viable deals and alliances in Asia.
A strategic and scientic conference that brings together all stakeholders with an interest in the science and business of R&D to discuss innovative methodologies and technologies in fast-tracking drug discovery.
Meet & network with senior level executives
A strategic platform where industrial stakeholders discuss best strategies to further strengthen their supply chain through achieving reliable and cost effective supply chain and logistics systems in Asia.
A strategic conference where senior level executives from leading Asian and global drug manufacturers discuss strategies in advancing manufacturing capabilities through partnerships and technologies.
Over 50 hours of networking opportunities
A dedicated platform where buyers and sellers come together to discuss best outsourcing strategies and successful partnership case studies in Asia.
A dedicated platform where buyers and sellers come together to discuss early drug developments strategies to expedite drug development in Asia.
Attend thought-provoking presentations
100 emerging biotechs will be delivering 15-minute presentations to showcase their most compelling discoveries and innovations! If you are an Asian biotech, register now and get a chance to speak for free at our Asian Biotech Forum.
Find out how you c particip Contact Katrina Leu or email katrina.leu
perience
I truly enjoyed the conference of BioPharma Asia Convention 2011 in Singapore. Because of this conference, I could do immediate action for my business in Singapore and have meetings with key stakeholders in this industry. Jin-San Yoo, President & CEO, PharmAbcine, South Korea
Networking opportunities
A by-invitation only event that brings together C-level executives from pharmas, biotechs and solution providers to discuss strategies, partnerships and outlook of Asias pharma industry.
Participate in on-oor seminars for targeted learning
CEO Breakfast Forum
Arrange one-to-one meetings with your potential partners. Through our CONTACT system, you can maximise your time by meeting the right people.
1 to 1 Meetings Awards Exhibition Area Country Pavilions
Join the celebration as we recognize the industry players who have contributed to the growth and success of the biopharmaceutical industry in Asia.
Explore partnership opportunities with key decision makers
Over 500 products will be showcased to target buyers from the entire value chain of the biopharmaceutical industry. Over 4000 potential buyers will be at the exhibition. This will be a great platform to maximise your lead generation. Asian and global countries will be sharing investment and partnership opportunities for start up and emerging companies. Find out more about the business opportunities available in their countries bioparks, bioclusters and biotech organisations.
Unlimited learning experience

Engage and build rapport with industry partners
More than 60 seminar sessions covering strategic to technical topics of the biopharmaceutical industry. High-level to mid-level management and technical experts from pharmaceuticals, biotechs and solution providers will discuss focused topics such as: Country collaborations Pharma IT Operational excellence Automation Pharma marketing RFID Scientic research & innovation
Visit country pavilions and learn about business opportunities in each country
66 on-oor seminar sessions Poster Showcase Workshops

7
Top 100 Asian research institutes will be presenting their latest R&D developments to potential investors and partners.
can customize your pation. ung at +65 6322 2322 ung@terrapinn.com
Dedicated sessions conducted by leading industrial experts that focus on the best industry practices and are inspired by the latest business trends and groundbreaking knowledge. Complete your participation experience and enrich your learning curves by participating in these workshops.
Event at a glance
Monday, 19 March 2012: Pre-conference summits & workshops
09:00 Workshop: Technology transfer, IP protection & licensing strategies Preclinical World Asia Contract Manufacturing World Asia Workshop: Designing & commissioning of future biomanufacturing facilities Workshop: Successful cold chain management strategies in Asia Workshop: Innovative methodologies to accelerate drug discovery
18:00
Welcome Cocktail Reception
Tuesday, 20 March 2012: Conference Day 1

09:00
Asian & global leadership forum

Asias role in the pharmaceutical industrys rapid transformation, changing business models & search for innovation
10:20 11:15
Morning refreshments, exhibition visit & academic poster showcase
Investment trends, opportunities & challenges across the life science sector
Strategic partnerships & collaborations
Biomanufacturing technology & development
Operational excellence
Supply chain network management
Trends & developments for R&D in Asia
12:30 14:00
Networking luncheon, exhibition visit & academic poster showcase Partnering, licensing & joint ventures Clinical trial design & operations Biosimilars & biobetters Optimising manufacturing processes Safety & quality control Innovative strategies in global & Asian drug research & discovery
15:30 16:15
Afternoon refreshments, exhibition visit & academic poster showcase Innovative business models Business models & outsourcing strategies Cell culture & upstream processing Quality by design LSP-client relationship New approaches & developments in key therapeutic areas
18:00
BioPharma Asia Industry Awards Dinner 2012
This forum was the perfect mix of networking events and talks where we could catch up with our industrial peers and learn from each other at the same time. Mark Benedyk, Managing Partner, Rila Partners, USA
Wednesday, 21 March 2012: Conference Day 2

07.30 09:00
CEO Breakfast Forum
Investment opportunities for life science funds
Regulatory challenges in Asia
Vaccine development & production
GMP compliance
Clinical supply management strategies
Promising drug discovery & development strategies in Asia
10:20 11:15
Morning refreshments, exhibition visit & academic poster showcase Investment opportunities for VC,PE & dedicated life science funds in Asia Market access East Asia: Japan, Korea & Taiwan Downstream processing Facility design & engineering Cold-chain management Optimising processes & strategies during drug discovery & development
12:30 14:00
Networking luncheon, exhibition visit & academic poster showcase Alternative capital & nancing strategies for life science companies Market access South East Asia: Emerging markets Recovery & Purication Lean & capacity management Inventory management Biomarkers in translational research
15:30 16:15
Afternoon refreshments, exhibition visit & academic poster showcase Risk assessment & exit strategies Market access India & China Disposable & single-use technology Automation & IT showcase Packaging, labeling, & transportation Promising research & technology developments
17:00
Closing Cocktail Reception
Thursday, 22 March 2012: Post conference workshops

09:00
Workshop: Positioning your company portfolio to increase deal value
Workshop: Effective clinical trial project management
Workshop: Development & production strategies for biosimilars
Workshop: Automation strategies for improved GMP compliance
Workshop: Effective applications of lean six sigma supply chain
Workshop: Utilising innovative technologies to formulate novel drugs effectively
17:00
End of Biopharma Asia Convention 2012 See you at Biopharma Asia Convention 2013
Unlimited learning experience and networking opportunities awaits you! Register before 31 Dec 2011 and save up to SGD1600
your
ultimate
networking
bringing you dedicated face-to-face time with the industrys stakeholders

The 5th annual BioPharma Asia Convention 2012 comes alive as we present you with the best socials yet! Make the most of your visit and leverage on the numerous networking opportunities this strategic gathering has to offer!
Welcome cocktail reception

Monday, 19 March 2012, 7pm 9pm Marina Bay Sands, Singapore
BioPharma Asia Convention 2012 kicks off in style with a welcome party platform for all our speakers, sponsors and attendees to network and make new contacts. Do not miss this opportunity to participate in an informal and inviting cocktail reception that brings you into the networking fold for the days ahead.
schedule
2nd annual BioPharma Asia Industry Awards

Build rap port w ess par ith busin tners & in dustry p eers
Tuesday, 20 March 2012, 6.30pm 9.30pm Marina Bay Sands, Singapore

Culminate an eventful day of networking and rapport building with the industrys stakeholders by participating in the Awards Dinner that seeks to showcase and celebrate excellence in the Asian biopharmaceutical industry. A perfect opportunity to build new relations in a relaxing and entertaining environment!
Recogn izing the outstan in Asia d
ing achie
vements
of the in
dustry p
layers
Closing cocktail reception

Wednesday, 21 March 2012, 5pm 6.30pm Marina Bay Sands, Singapore
A chance to relax and unwind after four packed days of learning and networking with industry professionals! Solidify existing alliances and reect on things that you have learnt at BPA2012.
ut busine ss d explo ideas an re growth opportun ities in
abo Discuss Asia
Contact Rebecca Koh at +65 6322 2725 or email rebecca.koh@terrapinn.com to nd out how you can maximize your brand exposure at the event
10
biopharma
Tuesday, 20 March 2012, 6.30pm 9.30pm Marina Bay Sands, Singapore

The 2nd annual BioPharma Asia Industry Awards 2012 seeks to celebrate Asias evolving importance as a destination for life science partnerships and business activities. It is at BioPharma Asia Industry Awards that the best individuals and organisations in the industry are recognised for their outstanding achievements and contributions to the biopharma sector in Asia. Reserve your seats now at BioPharma Asia Industry Awards to maximize on the unparalleled opportunities to network with Asias leading industry players and stakeholders and share in celebrating their success.
industry
awards
dinner
Make ne w contact ngthen s and stre existing business alliances
The 9 categories contested in 2012
Best Life Science LSP
Best Contract Research Organisation
Best Contract Manufacturing Organisation
Most Innovative Biotech

Celebra ting the industry s best at the A wards D inner
Global Executive of the Year
Asian Executive of the Year
Honoring
the co
ns of ntributio
leading p
layers in
Asia
Woman Executive of the Year
Socially Responsible Pharma of the Year
Best Manufacturing Solution Provider
Voting for the nal round of nalists begins on 16 January 2012! Visit www.terrapinn.com/2012/biopharma-asia-industry-awards to nd out who are the top 5 nalists shortlisted for each award category!
11
Partnering opport
Arrange 1 to 1 meetings with more than 4,000 potential partners
Take advantage of BioPharma Asia Conventions partnering opportunities!
BioPharma Asia Convention 2012 will bring together over 4,000 attendees from all over the world for four days of intense partnering. This event will gather stakeholders and decision makers from all across the entire value chain of the biopharmaceutical industry including licensing, investments, funding, drug discovery, manufacuturing, R&D, clinical trials, and supply chain. This is your best opportunity to meet with key decision makers in Asias biopharma industry. Through our CONTACT system, nding the right partners for your business has never been easier. Sign up now to participate at this strategic gathering and arrange facilitated one-to-one meetings with more than 4,000 prospects from the Asian and global biopharmaceutical industry. Our CONTACT system will allow you to: Review partnering opportunities by industry search options such as pharmas, biotechs, CMOs, CROs and more Select and shortlist prospects from hundreds of company proles Send, accept or decline requests for meetings Send personalised messages directly to event attendees Manage all conference activities in your personal agenda Customise your company and personal prole for 4000 over attendees to view Arrange and conrm pre-scheduled one-to-one meetings
w Meet ne
business
prospect
Unders
tand the
busines
s needs
of your
clientele
Dont waste precious time! Start arranging your business meetings as early as now! Maximize your business potential in Asia and generate new business leads from pre-qualied prospects!
Participat
e in
50 more than
hours of
network
ing
Contact Rebecca Koh at +65 6322 2725 to share with us more about your business objectives and who you would like to meet at this convention and let us arrange these meetings for you!
12
tunities
Country pavilions
Australia Austria Belgium Brazil Canada China Denmark Dubai Finland France Germany Hong Kong India Ireland Italy Israel Indonesia Japan Malaysia Netherlands Philippines
Terrapinn really knows how to gather important decision makers! Our stand was continuously busy and we have made some excellent contacts for our future business.
Don Grubb, Senior General Manager, Pharmaniaga LifeScience, Malaysia
BioPharma Asia Convention 2012 is well supported by the various regions trade agencies and biotech industry organizations. Life science companies from Europe, Asia and USA are invited to join the respective country pavilions to showcase their products, services and solutions.
Countries represented at BioPharma Asia Convention:

BioPharma Asia Convention 2012 comprises of attendees from the following countries:
Russia Saudi Arabia Singapore Spain Sweden Switzerland Taiwan Thailand United Kingdom United States Vietnam
Republic of Korea
Contact Renee Tan at renee.tan@terrapinn.com to nd out how you can be part of the pavilions today! Partnering associations & research institutes
BioPharma Asia Convention 2012 is honored to have the following organisations partner the event:
Association of Clinical Research Professionals (ACRP) Japan, Japan Association of Medical & Bio-Informatics Singapore, Singapore Association of Community Pharmacists of India (ACPI), India Centre for Cellular & Molecular Platforms (C-CAMP), India European Association of pharma Biotechnology (EAPB), Germany Genome Institute of Singapore (A Star), Singapore Hungarian Biotechnology Association, Hungary Innovaro Pharmalicensing, United Kingdom Korea International Trade Association (KITA), Korea Korea Biotechnology Industry Organisation (KoreaBIO), Korea Manipal Univesity, India Pharmaceutical Research and Manufacturers Association (PReMA), Thailand Pan-Asian Clinical Research Association Ltd, Singapore Singapore Society for Microbiology and Biotechnology (SSMB), Singapore Society of Clinical Research Professionals (SCRPM), Malaysia Taiwan Pharmaceutical Marketing & Management Association (TPMMA), Taiwan UCSD SKAGGS School of Pharmacy and Pharmaceutical Sciences, USA
Contact Valerie Lim at valerie.lim@terrapinn.com to nd out how you can be a supporting partner of this conference.
13
CONFERENCE PHARMA PARTNERING & INVESTMENT WORLD ASIA 2012
DAY ONE
08.00 08.40 08.45 09.00 10.20
Tuesday 20 March 2012
DAY TWO
08.30 08.50
Wednesday, 21 March 2012
Registration and refreshments Organisers welcome remarks: Terrapinn Asia Chairmans opening remarks
Registration and refreshments Chairmans opening remarks
ASIAN & GLOBAL LEADERSHIP FORUM

Asias role in the pharmaceutical industrys rapid transformation, changing business models & search for innovation Morning refreshments, exhibition visit & academic poster showcase
INVESTMENT OPPORTUNITIES FOR LIFE SCIENCE FUNDS
9.00
Success strategies in identifying & evaluating investment prospects in Asia John Diekman, Founder & Managing Partner, 5AM Ventures, USA A. Sinclair Dunlop, Managing Partner, Rock Spring Ventures, USA Lu Hong Bo, Executive Director for Asia, Orbimed, China
INVESTMENT TRENDS, OPPORTUNITIES & CHALLENGES ACROSS THE LIFE SCIENCE SECTOR
09.30
11.20
Capitalising on Asia as a source of growth & innovation for pharmas to narrow the gap in their pipelines Helmut Haning, SVP, Head Global Innovation Sourcing, Bayer Healthcare, Germany Paul Bolno, VP, Head of Asia, WWBD, GlaxoSmithKline, China Anders Ekblom, EVP, Global Medicines Development, AstraZeneca, Sweden
Collaboration for success: Managing the expectations on both sides of the partnerships A. Sinclair Dunlop, Managing Partner, Rock Spring Ventures, USA Innovative Company showcase Morning refreshments, exhibition visit & academic poster showcase
09.50 10.30
11.50
Analysing the paradigm shift from the traditional R & D towards new emerging partnerships Helmut Haning, SVP, Head Global Innovation Sourcing, Bayer Healthcare, Germany Leveraging on Asian biotechs as a means of ensuring continuous growth of global pharmas Kiran Mazumdar Shaw, Managing Director & Chairman, Biocon, India Networking luncheon, exhibition visit & academic poster showcase
INVESTMENT OPPORTUNITIES FOR VC, PE & DEDICATED LIFE SCIENCE FUNDS IN ASIA
12.10
11.15 11.35 11.55 12.15
Structuring high yield life science portfolio for maximum return Aditya Kapil, Principal, Ventureast, India How emerging companies from Asian biotech hubs can effectively tap into available funding opportunities Lu Hong Bo, Executive Director for Asia, Orbimed, China Going beyond borders to build value in Asian healthcare investments Ma Hui Hsing, Venture Partner, TVM Capital, Germany Networking luncheon, exhibition visit & academic poster showcase
12.30
PARTNERING, LICENSING & JOINT VENTURES
14.00
Comparing business development strategies in Asia Harvinder Popli, Director, Licensing, Ranbaxy Laboratories, India Anand Gautam, Director, Biopharmaceutical Scouting, Novo Nordisk, Denmark Hemant Pachnanda, Director, Business Development & Strategy, Sano-Aventis, Singapore Critical issues in protecting & maximizing IP value in a dynamic market environment Peter Homberg, Partner, Raupach & Wollert-Elmendorff, Germany Positioning your company for M&A Ken Araki, Senior Director, Corporate Strategy & Planning, Takeda Pharmaceutical, Japan Afternoon refreshments, exhibition visit & academic poster showcase
14.30 14.50 15.30
ALTERNATIVE CAPITAL & FINANCING STRATEGIES FOR LIFESCIENCE COMPANIES
14.00
Translation of government led incentives into the lifescience industry & economic growth Dato Nazlee Kamal, CEO, Malaysian Biotechnology Corporation, Malaysia Presenting proof of concept to access government & alternative funding Carrie Hillyard, Director, CM Capital Investments, Australia Country Investment Forum Afternoon refreshments, exhibition visit & academic poster showcase
14.20 14.40 15.30
INNOVATIVE BUSINESS MODELS
16.15
Leveraging on partnerships in accessing the markets of China Paul Bolno, VP, WWBD, Head of Asia, GlaxoSmithKline, China Paul Casey, VP & Head of Asia, Corporate Development, Quintiles, Singapore Emma Davies, Partner, Clifford Chance, China Analysing the business partnership models of mid - sized pharmas with Asian counterparts Donald Rindell, Executive Director, Amylin, USA Deanna M. Petersen, VP, Business Development, Shire Human Genetic Therapies, USA Ravi Sodha, Senior Director, Business Development, Acetelion, Switzerland Alternative partnering models for lifescience ventures Alfred Scheidegger, Founding Partner & CEO, Nextech Invest, Switzerland Chairmans closing remarks End of conference day one
RISK ASSESSMENT & EXIT STRATEGIES
16.45
16.15 16.35 16.55 17.15 17.20
Recognising the criteria that VCs look for when investing in small startup companies Goro Takeda, Venture Partner, Sonnova Ventures, Japan Private equity to public markets: Is exit an aim? John Diekman, Founder & Managing Partner, 5AM Ventures, USA Valuation in life sciences: How to put a value on license contracts & biomedical companies William Hu, Partner, Qiming Ventures, China Chairmans closing remarks End of conference day two
17.15 17.35 17.45
14
CONFERENCE PHARMA TRIALS WORLD ASIA 2012
DAY ONE
08.00 08.40 08.45 09:00 10:20
DAY TWO
08.30 08.50 09.00
Registration & refreshments Chairmans opening remarks
REGULATORY CHALLENGES IN ASIA

Overcoming regulatory barriers in Asia to fast-track clinical trials Joseph Scheeren, SVP & Head, Global Regulatory Affairs, Bayer Healthcare, USA Young-ok Kim, Director, Clinical Trials Management Division, Risk Prevention Policy Bureau, KFDA, South Korea Krisztina Nemenyi, Group Director, Asia Pacic, International Global Regulatory Sciences, Bristol-Myers Squibb, South Korea Customising your regional regulatory strategy Joseph Scheeren, SVP & Head, Global Regulatory Affairs, Bayer Healthcare, USA Aligning with the various regulatory requirements in Asia for successful clinical trial submissions Andrew Notley, Director, Regulatory Affairs, RPS, Australia Accelerating regulatory approvals for clinical trials in Asia Tetsuomi Takano, Senior Director & Head, Asian Project Management, Asian Development, Astellas Pharma, Japan Morning refreshments, exhibition visit & academic poster showcase

STRATEGIC PARTNERSHIPS & COLLABORATIONS
09:30 09:50 10:10 10:30 11:15
11:15 11.20
Chairmans opening remarks Michael Klein, VP, Clinical Development, Site Services Quintiles, Singapore Keynote: Strategic alliances: Building blocks to growth in Asia Bhavani Sivalingam, Head, Asia Clinical Alliances, Asia Pacic, Quintiles, Singapore Pzers global clinical development strategy with collaborations in Asian powerhouses India & China Salomon Azoulay, SVP, Medical & Development, Emerging Markets/Established Products Business Units, Pzer, USA Forging open partnerships between pharmas & biotechs to foster increased innovation in Asian clinical development Jeffrey Kasher, VP & COO, Global Clinical Development, Eli Lilly, USA Networking luncheon, exhibition visit & academic poster showcase
11.40
MARKET ACCESS EAST ASIA

Exploiting the favourable environment in East Asia Cristina Chang, Medical Director, Taiwan & Korea, Abbott, Taiwan Tetsuomi Takano, Senior Director & Head, Asian Project Management, Asian Development, Astellas Pharma, Japan Seong-Choon Choe, SVP, Chief Medical Ofcer, Hanall Biopharma, South Korea Harmonising regional strategies of clinical trial operations in East Asia to enhance operational efciency Cristina Chang, Medical Director, Taiwan & Korea, Abbott, Taiwan Developing innovative biomedicine in South Korea Seong-Choon Choe, SVP, Chief Medical Ofcer, Hanall Biopharma, South Korea Networking luncheon, exhibition visit & academic poster showcase
12.00
12.20
11:45 12:05 12.25 14:00 14.20 14:40 15:00
CLINICAL TRIAL DESIGN & OPERATIONS
14:00
Leveraging on integrated innovative technology to increase trial design efciency Graham Bunn, VP, Partnerships & Alliances, Medidata Solutions, UK Utilising clinical technology to accelerate your trial progress Christopher Fang, Worldwide Director, Clinical Research & Medical Affairs, DePuy Spine, Johnson & Johnson, USA Increasing protocol compliance during clinical trials through effective use of technology Malcolm Burgess, EVP, APAC, ICON Clinical Research, Hong Kong Afternoon refreshments, exhibition visit & academic poster showcase
14:30
MARKET ACCESS SOUTH EAST ASIA

Measuring sustainability of clinical trial studies in Indonesia Rianto Setiabudy, Prodia Expert Team, Prodia Group, Indonesia Planning your studies in South East Asia Alvin Luk, Senior Director, Global Clinical Affairs & Operations, Biogen Idec Hemophilia, USA Improving your trial design in Asia for enhanced quality Patrecia Valone, Director, Development Operations, Takeda Global Research & Development Centre, Singapore Mapping out the challenges & opportunities for clinical trials in South East Asia Alvin Luk, Senior Director, Global Clinical Affairs & Operations, Biogen Idec Hemophilia, USA Trang Nguyen Hoang Hanh, Head, Medical Affairs & Clinical Operations, Sano-Aventis, Vietnam Rikrik Ilyas, Managing Director, Innogene Kalbiotech, Singapore Afternoon refreshments, exhibition visit & academic poster showcase
15:00
15:30
BUSINESS MODELS & OUTSOURCING
16:15
Emerging South-East Asia: Capitalising on the heterogeneity of different markets to achieve clinical trial excellence Kenneth Lee, Senior Director, Scientic Affairs, Asia, PRA, Singapore Determining your business strategy in Asia: Not one size ts all Customising solutions for different needs Shashidhar Rao, Head, Global Medical Affairs, India Operations, Novartis, India Larry Ajuwon, Senior Outsourcing, Genzyme, Netherlands Werner Katzmann, Senior Director, Regional Medical Affairs, Asia Pacic, Biogen Idec, Singapore Yan Li, Head, Clinical Development, Oncology, Infectious Disease, Respiratory & Immunology, Emerging Markets, Merck, USA
16:45
15.30 16.15
MARKET ACCESS INDIA & CHINA

Optimising clinical trials in Asian powerhouses India & China Kezhou Zhang, VP, Medical Director, Novo Nordisk, China Qayum Mukaddam, VP, Medical Services, Abbott, India Hua Mu, SVP, Clinical Research & Development, Hutchison MediPharma, China Addressing key issues in post-marketing studies in India Qayum Mukaddam, VP, Medical Services, Abbott, India Improving your clinical trial operations in China Yan Li, Head, Clinical Development, Oncology, Infectious Disease, Respiratory & Immunology, Emerging Markets, Merck, USA Chairpersons closing remarks End of conference day two
16:45 17.05 17.25 17.30
17:15 17:20
Chairpersons closing remarks End of conference day one
15
CONFERENCE BIOLOGIC MANUFACTURING WORLD ASIA 2012
DAY ONE
08:00 08:40 08:45 09:00 10:20 11:15
DAY TWO
08:30 08:50
Registration and refreshments Organisers Opening Remarks: Terrapinn Asia Chairpersons Opening Remarks
Registration and refreshments Chairmans opening remarks Uwe Gottschalk, Group VP, Purication Technologies, Sartorius Stedim Biotech, Germany

Asias role in the pharmaceutical industrys rapid transformation, changing business models and search for innovation Morning refreshments, exhibition visit & academic poster showcase Chairmans opening remarks
VACCINE DEVELOPMENT & PRODUCTION
09:00
Managing the needs of vaccine manufacturing in Asia for improved manufacturing operations Tony DAmore, Vice President, Process Development, Sano Pasteur, Canada Quality by design in vaccine development & manufacturing Jacks Lee, Vice President, Vaccines, Pharmaceuticals & Sterile Operations, Merck Sharp & Dohme, USA Commercial preparation of acellullar pertussis vaccine through effective recovery and purication using tangential ow ltration Rakesh Kumar, Director, Vaccine Production, Serum Institute, India Morning refreshments, exhibition visit & academic poster showcase
09:20 09:40
BIOMANUFACTURING TECHNOLOGY & DEVELOPMENT
11:20
Growth opportunities for biologics manufacturing industry in Asia: Will Asia complement or replace their western counterparts? Wei-Kuang Chi, Vice President, Development Center for Biotechnology, Taiwan Tony DAmore, Vice President, Process Development, Sano Pasteur, Canada David Shen, Vice President & Global Head, Biologics Research & Early Development, Teva Pharmaceuticals, USA
10:00
DOWNSTREAM PROCESSING
11:15
11:50
Utilising emerging technologies to develop commercially scalable manufacturing platforms for biotherapeutic production Svend Erik Licht, Senior Director, Novozymes, Denmark Networking luncheon, exhibition visit & academic poster showcase
Developability Index: A rapid In Silico tool for the screening of antibody aggregation propensity Bernhard Helk, Global Executive Director, Technology Development, Novartis, Switzerland Scaling up for successful integration of protein production in commercial manufacturing Gunter Jagschies, Director, Customer Applications, R&D, GE Healthcare Recognising challenges in scale-up of proteins produced from microbial fermentation Chandrakant Kathote, Senior Director, Manufacturing, Fermentation Derived Products, Biocon, India Networking luncheon, exhibition visit & academic poster showcase
11:35
12:10
11:55
BIOSIMILARS & BIOBETTERS
14:00 14:20
Worldwide experience in biosimilar development David Shen, Vice President and Global Head, Biologics Research & Early Development, Teva Pharmaceuticals, USA Evolution of comparability for biologics: Uncovering important scientic and regulatory considerations Wassim Nashabeh, Global Head, Technical Regulatory Policy & Strategy, Genentech, USA Developing biosimilars for success Hanwhas bio business units experience Paul Coleman, COO, Bio Business Unit, Hanwha Chemical, South Korea Afternoon refreshments, exhibition visit & academic poster showcase
12:15
RECOVERY & PURIFICATION TECHNIQUES
14:00 14:20 14:40 15:00
14.40
Optimising the quality of vaccines with the removal of host cell residuals Ke Wu, President and Founder, Shanghai BravoBio, China Enhancing process efciency through process integration Pankaj Tahiliani, Technical Lead, Asia, PALL Life Sciences, India Non-chromatographic methods for purication of antibodies: Do we reinvent the wheel? Afternoon refreshments, exhibition visit & academic poster showcase
15:00
CELL CULTURE & UPSTREAM PROCESSING
16:15
Analytical method development strategy for cell line selection and process development Mahbubur Rahman, Deputy Director, Analytical Biochemistry, Analytical Process & Technology, Industrial Operations, Sano Pasteur, USA Enhancing yield and quality of biotherapeutics via host cell engineering Christian H. Leist, Head, Bioprocess Development Group, Novartis, Switzerland Chairpersons closing remarks End of conference day one
DISPOSABLE & SINGLE-USE TECHNOLOGY
16:15
16:35
Enhancing contract manufacturing operations in Asia with single-use systems Jason Li, Director, Downstream Processing, Genor BioPharma, China Optimising your biologic manufacturing operations through single-use technologies application Berthold Boedeker, Head, Cell Culture and Pilot Plants, Global Drug Discovery & Biotech Development, Bayer Schering Pharma, Germany Chairpersons closing remarks End of conference day two
16:35
16:55 17:00
17:15 17:20
16
CONFERENCE PHARMA MANUFACTURING WORLD ASIA 2012
DAY ONE
08:00 08:40 08:45 09:00 10:20 11:15 11:20 11:50
DAY TWO
08:30 08:50 09:00 09:20
Registration and refreshments Organisers Opening Remarks: Terrapinn Asia Chairpersons Opening Remarks
GMP COMPLIANCE
Harmonising global pharmaceutical manufacturing regulations Greg Guyer, SVP, Global Quality, Merck & Co., Inc., USA Leveraging on manufacturing compliance and quality to capture prot growths Michael Lee, VP, Manufacturing, Biomabs Pharmaceuticals, China Navigating the complex eld of GMP and regulatory compliance of the API industry Vinay Nayak, President, Alembic Pharmaceuticals Limited, India Morning refreshments, exhibition visit & academic poster showcase

Asias role in the pharmaceutical industrys rapid transformation, changing business models and search for innovation Morning refreshments, exhibition visit & academic poster showcase Chairmans opening remarks
09:40
OPERATIONAL EXCELLENCE
Manufacturing, development, efciency and exibility Esther Alegria, VP, Manufacturing, Biogen Idec, Denmark Manufacturing excellence: Sustaining momentum of a lean transformation Christian Houborg, VP, Service & Technical Operations and Lean, Lundbeck, Denmark Cost reduction by design strategies for efcient manufacturing operations Networking luncheon, exhibition visit & academic poster showcase
10:00
FACILITY DESIGN & ENGINEERING
11:15
12:10 12:30
Designing a exible manufacturing facility that caters to future demands Rajesh Hedaoo, Head - Projects & Manufacturing, Reliance Pharmaceuticals, India Employing technology transfer for optimal operational processes Ben Chen, VP, Formosa Laboratories, Taiwan Networking luncheon, exhibition visit & academic poster showcase
11:35 12:00
OPTIMISING MANUFACTURING PROCESSES
14:00
Optimising operational processes & eradication of defects due to human interaction through DDFP Victor Torres, Lean Bioscience Division Leader, Baxter Bioscience, France Optimising fermentation control with optical cell growth sensors Thomas Steckenreiter, Marketing Director, Endress+Hauser Conducta, Germany IT tool for quality risk management Flemming Simonsen, Senior Director, Global QA, Quality System & Tools, Ferring Pharmaceuticals, Switzerland Afternoon refreshments, exhibition visit & academic poster showcase
LEAN & CAPACITY MANAGEMENT
14:20
14:00
Applying lean to the overall value chain of a continuous process organisation Pierre Nader, Director of Operational Improvement & Excellence, Pzer, UK Increasing throughput through collaboration and capacity management Kim Sandell, Director, Operations Management & Operational Excellence, Pzer, Sweden The advantages of conquering complexity and executing corporate strategy with lean six sigma Afternoon refreshments, exhibition visit & academic poster showcase
14:40 15:00
14:20
14:40 15:00
QUALITY BY DESIGN
16:15
Gaining commercial advantages through utilisation of QbD approach to process development Klaus Kaiser, Head GMP Purication Global / Global Biological Development, Bayer Healthcare LLC, Germany Utilising Design of Experiments (DOE) as a tool to introduce exibility and implement QbD Chairpersons closing remarks End of conference day one
AUTOMATION & IT SHOWCASE
16:15 17:00 17.10
16:35 16:55 17:00
Automation and IT Showcase: Dedicated sessions for key global and Asian automation and IT solution providers to showcase their products and solutions Chairpersons closing remarks End of conference day two
Register now and gain access to more than 6 conference tracks and numerous networking sessions throughout BioPharma Asia Convention 2012
17
CONFERENCE DRUG DISCOVERY WORLD ASIA 2012
DAY ONE
08.00 08.40 08.45 09:00 10:20
DAY TWO
08.30 08.50
Registration and refreshments Organisers welcome remarks Chairmans opening remarks
Registration & refreshments Chairmans opening remarks

PROMISING DRUG DISCOVERY & DEVELOPMENT STRATEGIES IN ASIA
09.00 09.20 09.40 10.00
Insights into next generation drug discovery in Singapore Alex Matter, CEO, Experimental Therapeutics Centre, A*Star, Singapore An R&D strategy to achieving proof of value Shinichi Koizumi, SVP Research & CSO, RaQualia Pharma, Japan Lead discovery strategy at Institut Pasteur Korea Michel Liuzzi, Director, Early Discovery Program, Institut Pasteur, Korea Morning refreshments, exhibition visit & academic poster showcase
TRENDS & DEVELOPMENTS FOR R&D IN ASIA
11.15
Keynote: Pharmas & biotechs future R&D alliances Andreas Busch, Member of the Bayer HealthCare Executive Committee, Head of Global Drug Discovery, Bayer Healthcare, Germany Developing innovative business models & development strategies by new methods Yuan Xu, VP & Head, Biotherapeutics Development, Novartis, USA Medicinal chemistry outsourcing in Asia: Lessons learned David Wadsworth, Global Head Outsourcing & Operations, Roche, Switzerland Networking luncheon, exhibition visit & academic poster showcase
11.35
OPTIMISING PROCESSES & STRATEGIES DURING DRUG DISCOVERY & DEVELOPMENT
11.05
11.55 12.15
High throughput quantitative analysis of NCEs in biological uids: Can we achieve 10 sec analysis per sample. Olivier Heudi, Head, Translational Services, Novartis, Switzerland Understanding drug-protein interactions: Addressing the attrition rate in drug development Lihu Yang, Director Medicinal Chemistry, Worldwide External Research, Merck, USA Optimising strategies for HTS of drug lead discovery Guoxin Zhu, CSO/Head of China Chemistry, Discovery Chemistry Research & Technology, Eli Lilly, USA Utilising high throughput technologies in early development to accelerate time to clinic Sreehari Babu, Head, Chemical & Pharmaceutical Proling, Novartis, China Networking luncheon, exhibition visit & academic poster showcase
11.25
INNOVATIVE STRATEGIES IN GLOBAL & ASIAN DRUG RESEARCH & DISCOVERY
11.45 12.05
14.00 14.20
Delivering enhanced customer value: A collaborationcentric R&D model Atsushi Nagahisa, CEO, RaQualia Pharma, Japan Formulating lead validation strategies to explore the key factor for future success in target validation: An NMR based approach Koteppa Pari, Head Discovery Analytical, Piramal Healthcare, India Strategies & developments in next generation small molecule therapeutics Hans Joachim Boehm, Global Head of Chemistry, Center Manager for R&D Basel, Roche, Switzerland Afternoon refreshments, exhibition visit & academic poster showcase
12.25 14.00
BIOMARKERS & TRANSLATIONAL RESEARCH

Discovering modern personalised medicine with innovative biomarkers Iman El-Hariry, VP, Clinical Research, Synta Pharmaceuticals, USA Translation imaging for CNS drug discovery & development Chih-Liang Chin, Director & Site Lead, Imaging, Translation Medicine Research Centre, Merck Sharp & Dohme, Singapore Natural products for lead discovery: Teaching an old dog new tricks Martin Everett, Head of Research, MerLion Pharmaceutical, Singapore Afternoon refreshments, exhibition visit & academic poster showcase
14.40
15.00
14.20
NEW APPROACHES & DEVELOPMENTS IN KEY THERAPEUTIC AREAS
14.40
16.00
Formulating innovative & effective therapeutic treatments for neurodegenerative diseases Ceri Davies, VP, Head of GSK Singapore R&D Site, Head of Neural Pathways DPU, GSK, Singapore Encapsulated porcine islet transplants for treatment of diabetes Bob Elliott, CEO & Medical Director, Living Cell Technologies, New Zealand Exploiting immune system specicity to develop soluble molecules that target HBV infected hepatocytes Adam Gehring, Assistant Principal Investigator, Singapore Institute for Clinical Sciences, A*Star, Singapore Chairmans closing remarks & end of conference day one
15.00
16.20
PROMISING RESEARCH & TECHNOLOGY DEVELOPMENTS
16.00 16.20
16.40
The current status of the rst-in-class dual inhibitor of PI3K & Erk AEZS-132 Juergen Engel, President & CEO, terna Zentaris, Germany Deduction of novel phenotypes & disease mechanisms in uropathogenic E.coli using comparative evolutionary analysis Swaine Chen, Singapore NRF Fellow, Division of Infectious Diseases, National University of Singapore, & Infectious Diseases Group, Genome Institute of Singapore Accelerating drug discovery with uorescent-tagged antimalarials Kevin Tan, Scientic Director, Biolynx Technologies, Assistant Professor at Laboratory of Molecular & Cellular Parasitology, Department of Microbiology, National University of Singapore, Singapore Chairmans closing remarks & end of conference day two
17.00
Research institutes & academics only pay SGD600 if you register before 31 Dec 2011.
18
16.40
17.00
CONFERENCE PHARMA AND BIOTECH SUPPLY CHAIN WORLD ASIA 2012
DAY ONE
08.00 08.40 08.45 09.00 10.20
DAY TWO
08.30 08.50 09.00
CLINICAL SUPPLY MANAGEMENT STRATEGIES

Optimising your clinical supply chain with complex distribution by utilising Monte Carlo simulations Kunal Jaiswal, Director, Global Clinical Supply Planning, Merck, USA Overcoming business risks & uncertainties in a dynamic global supply chain network Prashant Sharma, Senior Vice President, Global Demand Supply Organisation & Global IT, Zydus Cadila, India Kunal Jaiswal, Director, Global Clinical Supply Planning, Merck, USA Shivraj Dasari, VP, Q.M.R.A, Inno Bioventures Sdn. Bhd., Malaysia Neeraj Bhargava, Director, Regional Logistics Procurement, Johnson & Johnson, Singapore

Asias role in the pharmaceutical industrys rapid transformation, changing business models and search for innovation Morning refreshments, exhibition visit & academic poster showcase
09.30
SUPPLY CHAIN NETWORK MANAGEMENT
11.20
Formulating strategies for quality assurance in response to changing supply chain management in Asia Shivraj Dasari, VP, Q.M.R.A, Inno Bioventures Sdn. Bhd., Malaysia Managing risk for temperature controlled transportation Ni Sheng Jie, Regional Multi-Country Account Director, TNT Asia Pacic, Singapore Exploring cost effective logistic strategies in emerging markets Kalyana Krishnan, Head, Global Supply Chain, Ranbaxy Laboratories, India Networking luncheon, exhibition visit & academic poster showcase
11.50 12.20
10.10
Morning refreshments, exhibition visit & academic poster showcase
COLD-CHAIN MANAGEMENT
11.15
12.50
Balancing exibility in cold chain movements with retention of the integrity and quality of pharmaceuticals Michael Lee, VP, Manufacturing, Biomabs Pharmaceuticals, China Utilizing passive thermal packaging technology to actively reduce risk Joachim Kuhn, Chief Executive Ofcer, Va-Q-Tec, Germany Networking luncheon, exhibition visit & academic poster showcase
SAFETY & QUALITY CONTROL
11.45 12.15
14.00
Creating the best products: Aligning your supply chain process with quality compliance Sam Zhou, Head, Security for Asia Region, Sano-Aventis, China Dening a holistic approach to protect your supply chain Pankaj Monga, Director, Brand Protection of Asia, Johnson & Johnson, India Afternoon refreshments, exhibition visit & academic poster showcase
14.30 15.00
INVENTORY MANAGEMENT
14.00 14.30 15.00
Co-ordinating inventory management for swift responses to changing market trends Formulating your success strategies for planning and purchasing cost management Prashant Sharma, Head, Supply Chain, Zydus Cadila, India Afternoon refreshments, exhibition visit & academic poster showcase
LSP-CLIENT RELATIONSHIP
16.15
Enhancing LSP-client relationships to optimise supply chain performance in Asia Frank Binder, Senior Director, International Logistics & Supply Chain, Celgene, Switzerland Maximising business growth opportunities by choosing the right LSP Melchizedek Camus, Contractor Relations Lead, Asia Pacic, Pzer Consumer Healthcare, Philippines Open-oor Interactive Session: Making the right decision Working with multiple LSP versus 3PLS Chairmans closing speech End of conference day one
16.45
PACKAGING, LABELING & TRANSPORTATION SHOWCASE
16.15
17.15 17.30 17.40
Global and Asian packaging and labeling solution providers will showcase their latest and most effective thermal packaging and labeling technologies and services. Contact Renee Tan at +65 6322 2785 or email renee.tan@ terrapinn.com to book your slot at the Automation & IT showcase now. Chairmans closing remarks End of conference day two
17.00 17.10
Meet key decision makers
Learn from leading experts
Find strategic partners
19
SUMMITS PRECLINICAL WORLD ASIA 2012
CONTRACT MANUFACTURING WORLD ASIA 2012
PRE-CONFERENCE SUMMIT
Monday, 19 March 2012
08.00 09:00 09.05
PRE-CONFERENCE SUMMIT
Monday, 19 March 2012
08:00 09:00 09:05
CHALLENGES & OPPORTUNITIES IN PRECLINICAL DEVELOPMENT IN ASIA
09.15 09.45 10.15
The role of Asia in preclinical development of pharmaceuticals Developing a sustainable business model for your preclinical drug development in Asia Assessing Asias competitiveness & growth opportunities in conducting preclinical trials Thomas Singer, EVP & Global Head, Non-Clinical Safety, Roche, Switzerland Michael DuVall, Associate Director, Toxicology, Abbott, USA Helen Han Hsu, Vice President & Head, Global Preclinical Development, Asia Pacic & Global Business Development, Johnson & Johnson, China Morning refreshments
GROWTH OPPORTUNITIES IN CONTRACT MANUFACTURING IN ASIA
09:15
Panel Session: The rise of Asian CMOs in the global pharmaceutical industry Uwe Bcheler, Senior Vice President, Biopharmaceuticals, Boehringer Ingelheim, Germany Batrice Serckx-Poucin, Associate Director, Local Manufacturing and CMO Governance, UCB Pharma, Belgium Ulrich Rmenapp, Contract Manufacturing Biotech, Head Biotech Projects, Bayer Pharma AG Effectively managing the increasing complexity at a CMO to ensure regulatory compliance Uwe Bcheler, Senior Vice President, Biopharmaceuticals, Boehringer Ingelheim, Germany Contract manufacturing Transitioning from tactical operations to strategic partnerships Morning refreshments, exhibition visit & academic poster showcase
09:55
10.55
PRECLINICAL DEVELOPMENT STRATEGIES
10:25 10:55
11.15
Developing an innovative preclinical model to drive R&D productivity Haiyan Jiang, Director, Preclinical & Clinical Research, Biogen Idec Hemophilia, USA Effectively managing preclinical studies input from global sites for your preclinical pipeline Wouter Schul, Associate Director, Preclinical Development & Portfolio Management, Novartis Institute for Tropical Diseases (NITD), Singapore Optimising your outsourcing partnership collaboration in Asia Stewart Geary, Vice President & Deputy Director, Corporate Regulatory Compliance & Quality Assurance Headquarters, Eisai, Japan Vivek Kadambi, Senior Director & Head, Drug Safety Evaluation, Millennium: The Takeda Oncology Company, USA Wouter Schul, Associate Director, Preclinical Development & Portfolio Management, Novartis Institute for Tropical Diseases (NITD), Singapore Networking luncheon
11.45
SUSTAINABLE CMO PARTNERSHIP MODELS
11:15
A pharmas perspective: Benets and challenges in outsourcing biopharmaceutical manufacturing Ulrich Rmenapp, Contract Manufacturing Biotech, Head Biotech Projects, Bayer Pharma AG Effective external partner integration and alliance management in Asia Batrice Serckx-Poucin, Associate Director, Local Manufacturing and CMO Governance, UCB Pharma, Belgium Networking luncheon
12.15
11:45
12:15 14:00 14:30 15:00 15:30
CMO MANAGEMENT STRATEGIES

Management of a complex network: Quality and audit within partnerships Developing effective monitoring processes to ensure quality output from your CMO Seeking value and ensuring innovation in the relationship with your CMO Afternoon refreshments
12.45
EXPLORATORY DEVELOPMENT & TOXICOLOGICAL STUDIES
14.00
Preclinical safety analysis of innovative drugs Stewart Geary, Vice President & Deputy Director, Corporate Regulatory Compliance and Quality Assurance Headquarters, Eisai, Japan Leveraging on innovative strategies to achieve improved toxicology results Vivek Kadambi, Senior Director & Head, Drug Safety Evaluation, Millennium: The Takeda Oncology Company, USA Comparing toxicological services for successful preclinical studies in India & China Michael DuVall, Associate Director, Toxicology, Abbott, USA Afternoon refreshments
14.30
ASIAN & GLOBAL CMO SHOWCASE
16:00 17:00 17:10
CMO Showcase: Presentations from key global & Asian CMOs Chairpersons closing remarks End of summit
15.00 15.30
ASIAN & GLOBAL CRO SHOWCASE
16.00 17.00 17.10
PreClinical Showcase: Presentations from key global & Asian preclinical CROs Chairpersons closing remarks End of summit
Register now to attend the summit and enjoy more than 50% in discounts!
20
WORKSHOPS PRE AND POST CONFERENCE WORKSHOPS
PRE-CONFERENCE WORKSHOP
Monday, 19 March 2012 | 9am-3pm
Designing, commissioning and validation of future biomanufacturing facilities
Facility planning is an important aspect of the manufacturing process due to their effect in achieving an efcient product ow. Manufacturing costs can be reduced by 30% through an effective facility planning and proper analysis of facility layout design could improve the performance of production line tremendously. Attend this workshop to learn about innovative approaches and techniques to design, commission, and validate biomanufacturing facilities effectively. Who should attend: Heads of Manufacturing | Operations | Production | Engineering | Pharmaceutical | Process Development
POST-CONFERENCE WORKSHOP
Thursday, 22 March 2012 | 9am-3pm
Effective clinical trial project management
Asia is now playing a greater role in global clinical trials with the increased globalisation of clinical trial studies. Hence there is a need to learn how to manage trials effectively from the head ofce or a regional ofce. Various factors that are critical in the clinical trial management process will be examined so as to accelerate the approval of the study and the drugs entry into the market. Who should attend: Clinical research associates | project management associates | clinical study coordinators | clinical trial investigators
Development and production strategies for biosimilars

The patent cliff as well as increasing user acceptance is main drivers of the booming biosimilar market. The workshop will provide attendees with key strategies for product development and manufacturing. The workshop will also explore key regulatory and scientic issues revolving biosimilar market. Who should attend: Heads of Manufacturing | Heads of Quality Assurance | Heads of Bioprocess
Technology transfer, IP protection & licensing strategies

In this current era to keep up with competition companies have realised that they now need to adopt measures such as technology transfer, IP protection and licensing strategies. There are many solutions to ensure you remain a key market player and this workshop looks at practical examples to ensure which strategy is the best for you to maintain your competitiveness in the industry as a key player. Who should attend: Heads of Licensing | Business Development | Patent Attorneys
Automation strategies for improved GMP compliance

In order to be at a competitive edge for pharmaceutical companies in innovative pharmaceutical development, manufacturing, and quality assurance, it is vital to develop initiatives to comply with the required cGMP requirements effectively. Attend this workshop to learn about automation strategies, GMP principles, qualication steps, and engineering process that will improve the success of drug development and manufacturing. Who should attend: Heads of Manufacturing | Operations | Production | Engineering | Pharmaceutical | Process Development
Innovative methods and bioinformatics to improve and accelerate drug discovery

With ever increasing data volumes and focus areas for drug discovery and development, complexities are also increasing. Innovative research and development methods are valuable in order to accelerate processes and achieve results faster. Attend this workshop to learn about new and proven technologies and developments coming from IT that can boost your R&D efforts and create strong results. Who should attend: Heads of Informatics | R&D | Drug Discovery | Global Research | CSOs
Positioning your company portfolio to increase your deal value

The rapid growth in Asia is presenting pharma and biotech companies with numerous partnership opportunities. Thus deal making is one of the most important aspects in a successful partnership. In this robust industry, one needs to have the ability to monetise assets to make the company attractive to potential investors or deal partners. This workshop will enable you to position your companys assets in the most strategic manner to Maximise your deal value. Who should attend: Business Development Managers | Academia | Clinicians
Successful cold chain management strategies in Asia

Proper implementation of temperature controlled packaging solutions continues to be a priority for stakeholders in the biopharmaceutical space and the industry has seen an increase in demand for high performance thermal packaging solutions that are both cost-effective and product and energy efcient. There is an increasing demand for cold chain support services for all phases of clinical development in Asia, especially with the shift of clinical trial studies and sites to this part of the world. Come to this workshop and nd out how you can ensure successful cold chain management at your organisation. Who should attend: Logistics | Supply Chain Personnel | Clinical Operations Personnel | Quality Personnel
Utilising innovative methods and technologies for formulation and drug delivery
Drug formulation and delivery are of central importance during the R&D phase in order to achieve bioavailable compounds that are effective in patient treatment. This workshop will teach you effective methods and ways to accelerate formulation development and increase the success rate while incorporating these processes effectively into the overall drug development process. Who should attend: Heads of Chemistry | R&D | Drug Discovery | Global Research | CSOs
Maximise your learning experience at BioPharma Asia Convention. Sign up now in groups to enjoy up to 25% discount in savings!
Effective applications of lean six sigma in supply chain management

Globalisation of markets, innovation in information technology and intense competition have forced companies to change the way they source, produce and distribute their products and services. Management has realised that effective global supply chain management is the key to improving service, increasing market share and prot Come to this workshop and nd out how you can implement Lean Six Sigma strategies to radically improve your organizations productivity and protability. Who should attend: Logistics | Supply Chain Personnel | Clinical Operations Personnel | Quality Personnel
21
Your best sales & marke
Conduct live demonstrations
Reinforce industry thought leadership
My objective for attending BioPharma Asia Convention is to network with a wide potential of clients who are very well represented here and it has been a good experience. Richard Soll, Senior Vice President, Integrated Services, Wuxi Pharmtech, China
Strengthen brand awareness
Showcase innovative products and services
This event has more relevant clinical decision makers than the other events that we have attended in this region, good for us. James Mash, CEO, Asia Global Research
Share technical expertise
Arrange private one-to-one meetings
I wanted to come to this meeting (Biopharma Asia Convention 2011) to specically get some answers around Asias biopharmaceutical needs and this conference has been great in achieving this objective. I will denitely recommend this event to my industrial peers to attend, it is a wonderful event.
Mindy D. Goldsborough, R&D Director, Advanced Bioprocessing, BD Bioscience, USA
Generate numerous business leads
22
eting opportunity in Asia

Maximise your business potential in Asia
Find out the latest innovation, technologies and products in the biopharmaceutical sector. More than 500 products and services offered by leading CROs, CMOs, pharmas, biotechs and service providers will be showcased at BioPharma Asia Convention 2012. A unique platform showcasing solution providers across the entire value chain, from drug discovery, R&D, preclinical, clinical, manufacturing to supply chain. If you would like to position yourself as an industry leader and meet face-to-face with your prospective clients in the biopharmaceutical space, you denitely need to be here! Contact us now and let us help you customize your participation experience according to your business development goals today!
4000+ Biopharma
professionals
500+ exhibitor products 100+

poster presentations
200+ high-level speakers 60+

exhibition seminars
1
big event
BioPharma Asia Convention 2012 Exhibition Floorplan

20 21 March 2012, Marina Bay Sands, Level 5, Singapore
Conrmed Reserved
To be part of this exhibition in showcasing your solutions and services, please contact: Rebecca Koh at +65 6322 2725 or email rebecca.koh@terrapinn.com Renee Tan at +65 6322 2785 or email renee.tan@terrapinn.com
23
About our sponsors

Diamond Sponsor ________________________________________________________ Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. With over 20 ofces in 14 countries in Asia, we nd a multitude of ways to help you turn healthy ideas into healthy people and accelerate outcomes. We offer both insight and action from strategic business consulting to operational delivery. Voted 2010 Asia Pacic CRO of the Year by Frost & Sullivan we have built our reputation in the region on the quality and results we have delivered across 1,700 studies involving 230+ partner and 4,000+ non partner sites. Quintiles combination of global, regional and local expertise across a range of therapeutic areas including oncology, vaccines, neurology and cardiovascular disease has never been more important. For more information, please visit www.quintiles.com. Platinum Sponsors _______________________________________________________ RPS, The Next Generation CRO, provides comprehensive global Phase I-IV clinical development solutions to the pharmaceutical, biotechnology and medical device industries. By combining an experienced clinical research operations infrastructure with the industrys largest resourcing engines, RPS is uniquely positioned to offer our Clients a broad spectrum of outsourcing solutions. These solutions range from globally integrated functional and cross-functional programs to enhanced global full service solutions, and are powered by highly experienced and seasoned project teams providing innovative, seamless, cost-effective and high quality services. TNT is among the worlds largest express operators and the number one in Europe. Worldwide, it delivers 4 million parcels, documents and pieces of freight a week to more than 200 countries. TNT continually expands its air and road network in Europe, Asia, Australia, South America and the Middle East, connecting international routes to fast growing domestic road networks. TNTs solutions for the clinical sector include a suite of services that support drug discovery and product development and the shipment of pharmaceutical products. Gold Sponsors ___________________________________________________________ Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative performance products, services and business relationships that enable our customers success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientic and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science. Pall Life Sciences The life sciences industry is both driven and united by its need for speed to market, product reliability and economics. Palls leading edge ltration, separation and purication technologies and services play an essential and pivotal role in this industrys ability to achieve these goals. In the laboratory, Pall products help to facilitate the drug discovery and development process to get innovative drugs to the market faster. In Biopharmaceuticals, Pall ltration, chromatography, sampling, monitoring and quality assurance products, together with technical services in validation, assays and process optimization are applicable to laboratory and pilot-scale development, aseptic processing, biologicals, bioprocessing, fermentation and downstream processing. Sartorius Stedim Biotech is a leading provider of cuttingedge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, ltration, purication, uid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientic community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions Silver Sponsors___________________________________________________________ Endress+Hauser is a leading supplier of critical process measuring instruments which are designed according to the rules, laws and guidelines for the regulated industries like Active Pharmaceutical Ingredient, Pharmaceutical and Biotechnology drugs producers, Personal Care Products manufacturers, etc. Total support from engineering, commissioning, maintenance, calibration to asset management solutions enables our customers to focus on their core competences, producing safe and high quality drugs and products. GE Healthcare provides life science research products and biopharmaceutical manufacturing technologies. Over 90% of the current biopharmaceuticals therapies on the market are manufactured utilizing chromatography media from GE Healthcare. In addition, our service organization helps you improve productivity and reduce costs associated with the upkeep of laboratory and manufacturing equipment. Bronze Sponsors _________________________________________________________ Clifford Chance is one of the worlds leading law rms, helping clients achieve their goals by combining the highest global standards with local expertise. Established in the early 1990s, Clifford Chances Global Healthcare and Life Sciences team consists of more than 80 dedicated lawyers in 30 key centres worldwide. Having cultivated an expertise in the industry over nearly two decades and worked with many of the worlds leading pharmaceutical, biotechnology, medical device and health care services companies, we understand the importance of anticipating regulatory and contractual issues in the context of corporate investment, nance, strategy and operations. ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. We have the operational exibility to provide development services on a stand-alone basis or as part of an integrated full service solution. Lambda Therapeutic Research Limited is a leading Clinical Research Organization (CRO) providing end-to-end Clinical Research services globally, since 1999. With its research facilities in India, Canada, Poland, UK and USA, Lambda provides Phase14 clinical research services including Clinical Trial Management, Medical Writing, Clinical Data Management (CDM), Biostatistics, Pharmacovigilance, Medical Imaging and Central Lab services. Lambda has carried-out studies across various therapeutic areas including Oncology and CNS segments. Lambda has been successfully audited by various Regulatory agencies including the USFDA. Medidata Solutions (www.mdsol.com) is a leading global SaaS provider of clinical development solutions that enhance the efciency of customers clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability. Novozymes develops and manufactures high quality animal-free, Q7 GMP compliant ingredients and technologies to support product development in medical device and pharmaceutical industry. With over 25 years experience in the pharmaceutical industry, Novozymes Biopharma is the world leader in the supply of biological based ingredients such as hyaluronic acid and recombinant albumin, and technologies for formulations and processing. For further information visit www.biopharma.novozymes.com PRA is one of the worlds leading global clinical research organizations, conducting clinical trials in more than 80 countries. PRA provides clinical services for all therapeutic areas, across all phases of pharmaceutical and biotech drug development, with signicant expertise in Oncology and Hematology, Neurosciences (neurology and psychiatry), Cardio Metabolic, Infectious Disease and Allergy/Respiratory Prodia the CRO is the rst full service of CRO in Indonesia which provides full support to pharmaceutical/ biotech industries or other CROs to conduct GCP clinical trials. Prodia the CRO offers wide range of outsourced services to answer our client needs in developing and accelerating drug process to the market.Prodia the CRO is committed to quality through qualied and dedicated resources. The organization has established networks with over 370 investigators and with more than 64 sites all over Indonesia. Raupach & Wollert-Elmendorff is a German commercial law rm providing comprehensive services to its clients. With almost 100 professionals in seven ofces throughout Germany we rank among the largest German law rms. Raupach is the German strategic partner of Deloitte and has access to a worldwide network of law rms in almost 40 countries and with more than 3.200 lawyers. Due to their longstanding professional experience in the Life Sciences Sector, Raupachs legal experts are highly qualied to support companies focusing on pharmaceuticals, diagnostics, biotechnology and medical devices in all legal matters. va-Q-tec is a complete provider of thermal shipping solutions which cover the entire lifecycle of pharmaceuticals with passive technology. By providing container trip rental, high performance packaging product and cold chain support services, we offer solutions for all phases of clinical development through to volume market distribution. va-Q-tecs passive packaging can maintain the required temperatures for 96 hour or more even in extreme ambient conditions without an electrical power supply or dry ice. Visit http://www.va-Q-tec.com for more information.
24
REGISTRATION
BOOK BEFORE 31 DECEMBER 2011 AND SAVE UP TO SGD1600
5th annual
Bio ASIA
Register now
Package
Life
CONVENTION 2012
19 22 March 2012, Marina Bay Sands, Singapore

Book before 31 December 2011 and save up to SGD1600
Price before 31 Dec 11 Price before 30 Jan 12 Price before 2 Mar 12 Price after 2 Mar 12 How Many Calculate your ticket
How to book your ticket Online

Its quicker and easier to book and pay online go to www.terrapinn.com/biopharma and click on register now
4 day pass (19 22 March 2012) Pre-conference workshop/summit + 2 day all access conference + Post-conference workshop 3 day pass (19 22 March 2012) l Pre-conference workshop/summit + 2 day all access conference (19 21 March 2012) OR l 2 day all-access conference + Post-conference workshop (20 22 March 2012) 2 day pass (20 21 March 2012) 2 day all-access conference 1 day workshop/summit pass (19 / 22 March 2012) l Pre-conference workshop/summit (19 March 2012) OR l Post-conference workshop (22 March 2012) Academic pass** (20 21 March 2012) 2 day all-access conference BioPharma Awards Dinner (20 March 2012) * All tickets include refreshments, lunch and full conference documentation. The fee does not include hotel accommodation. * Only one discount scheme applies * 7% GST applicable to local delegates. ** Terrapinn reserves the right to determine eligibility to academic pricing
S$3,795 S$2,995
S$4,295 S$3,495
S$4,795 S$5,395 S$3,995 S$4,595
Ofine
Complete this form and fax it back to +65 6223 3554 or call +65 6322 2770 and well take your booking over the phone.
S$1,995 S$1,495
S$2,495 S$1,995
S$2,995 S$3,595 S$2,495 S$3,095
Post
BioPharma Asia 2011 1 Harbourfront Place #18-01 Harbourfront Tower One, Singapore 098633 For more information, contact Huisan Soh at +65 6322 2770
S$600
S$700 S$250
S$800
S$1,000
Booking fee for Credit card payments Booking fee for Cheque / Bank Transfer payments
S$0 S$100
Group bookings
Why not send your team and save more. Send 3 delegates and save 10% Send 6 delegates and save 20% Call +65 6322 2770 or go online and register www.terrapinn.com/biopharma
Your details
Delegate name ......................................................................................................................................................................................................................... Job title ...........................................................................................................Organization .................................................................................................... Address .................................................................................................................................................................................................................................... Post code .........................................................................................................Country ............................................................................................................ Tel ....................................................................................................................Fax ................................................................................................................... Email......................................................................................................................................................................................................................................... Authorizing manager .......................................................................................Authorizing manager signature....................................................................... By signing and returning this form you are accepting our terms and conditions. To better customise your learning experience at BioPharma Asia Convention 2012, please ll in the following so that we may cater for banqueting and conference documentations to avoid wastages. Indications of your preferred choices do not restrict your access to the other conferences/summits/workshops. If you would like to register for the all-access conference pass, please select your preferred choice: If you have selected a package that includes summit or workshop, please indicate which summit and/or workshop that you will be attending as part of your selected package. Pre-conference summit (19 March 2012)
Privacy policy
Terrapinn (or its agents) may contact you by mail, phone or email about products and services offered by Terrapinn and its group companies, which Terrapinn believes may be of interest to you, or about relevant products and services offered by reputable third parties. Terrapinn may also disclose your contact details to such third parties to enable them to contact you directly. Certain entities to which Terrapinn discloses your contact details are located in territories overseas which have fewer legal safeguards to protect personal data. By returning this form to us, you agree to our processing of your personal information in this way. Please tick the appropriate box if you do not wish to receive such information the Terrapinn group; or reputable third parties.
20 21 March 2012
20 21 March 2012
20 21 March 2012
Cancellation policy
1. Should you be unable to attend, a substitute delegate is welcome at no extra charge; 2. Terrapinn does not provide refunds for cancellations. Invoiced sums are payable in full, except in cases where Terrapinn has been able to mitigate loss; 3. Terrapinn will make available course documentation to a delegate who is unable to attend and who has paid; 4. Terrapinn reserves the right to alter the programme without notice including the substitution, alteration or cancellation of speakers and / or topics and / or the alteration of the dates of the event; 5. Terrapinn is not responsible for any loss or damage as a result of a substitution, alternation, postponement or cancellation of an event.
20 21 March 2012
20 21 March 2012
20 21 March 2012
Pre-conference workshop (19 March 2012) Designing and commissioning of future biomanufacturing facilities Technology transfer, IP protection, & licensing strategies Innovative methodologies to accelerate drug discovery Successful cold chain management strategies in Asia
Post-conference workshop (22 March 2012)
Effective clinical trial project management Development and production strategies for Biosimilars Automation strategies for improved GMP compliance Positioning your company portfolio to increase deal value Utilising innovative technologies to formulate novel drugs
effectively
Effective applications of lean six sigma in supply chain
Payment details
Payment is due in 14 days. Bank transfer Crossed cheque payable to Terrapinn Pte Ltd
Mastercard
Card number
Card holder's name ......................................................................................... Card holder's signature ................................................................................

Bank Transfers: Payment by bank transfer must quote the delegate name and reference code: 131640. Transfers should be made to Standard Chartered Bank, 6 Battery Road, Singapore 049909. Account name: Terrapinn Pte Ltd, Account No. 01-008-9045-8
l--l-
Visa
American Express
JCB
For ofcial use only

Expiry date: _______/______ Received: Date:.............................. Code:131640 ABCDEFGHIJKLMNOPQRSTUVWXYZ
Biz Reg No.: 198902388R
25
Event sponsors
Diamond Sponsor: Platinum Sponsors:
Gold Sponsors:
Silver Sponsors:
Bronze Sponsors:
Country Pavilions:
Exhibitors:
Advertisers:
Supporting Agencies:
Media partners:
Supported by:
Organised by:
Join us now! Subscribe to our blogs on industry news and event updates. Join our LinkedIn group to participate in our discussions and play a part in crafting the future of the biopharmaceutical industry.
www.blogs.terrapinn.com/biopharma biopharmaasia BioPharma Asia Pacic
26

Brochure

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Brochure

Uploaded by

Copyright:

Available Formats

5th annual

Sign up before 31 December 2011 and save up to SGD1600

19 22 March, 2012 Marina Bay Sands, Singapore

Held together with:

Your gateway to Asias biop

Why you need to be at BioPharma Asia Convention 2012

Meet face to face with senior level decision makers

4000 500 200 100 66 50 9 1

*offer ends 16 Dec 2011

Key investors in Asias pharma industry

Carrie Hillyard Director CM Capital Investments, Australia

Yuan Xu Vice President and Head of Biotherapeutics Novartis, USA

Esther Alegria, Vice President, Manufacturing, Biogen Idec, Denmark

John Diekman Founder and Managing Partner 5AM Ventures, USA

Tony DAmore Vice President, Process Development Sano Pasteur, Canada

Kunal Jaiswal Director, Global Clinical Supply Planning Merck, USA

Goro Takeda Venture Partner Sonnova Ventures, Japan

Hear from more than 120

Biologic Manufacturing World Asia 2012

Pharma Trials World Asia 2012

Emerging biotechs in Asia

Industry thought leaders in Asia

Shivraj Dasari, Vice President Inno Bioventures, Malaysia

Rikrik Ilyas Managing Director Innogene, Singapore

Shermal Perera Managing Director Siogen, Malaysia

Cristina Chang Medical Director, Taiwan and Korea Abbott, Taiwan

Rakesh Kumar Director, Vaccine Production Serum Institute of India, India

Michel Liuzzi Director, Early Discovery Program Institut Pasteur, Korea

global and regional leaders

Drug Discovery World Asia 2012

Pharma & Biotech Supply Chain World Asia 2012

Pharma Manufacturing World Asia 2012

Customise your learning ex

Meet & network with senior level executives

Over 50 hours of networking opportunities

Attend thought-provoking presentations

CEO Breakfast Forum

1 to 1 Meetings Awards Exhibition Area Country Pavilions

Explore partnership opportunities with key decision makers

Unlimited learning experience

66 on-oor seminar sessions Poster Showcase Workshops

can customize your pation. ung at +65 6322 2322 ung@terrapinn.com

Welcome Cocktail Reception

Tuesday, 20 March 2012: Conference Day 1

Asian & global leadership forum

Morning refreshments, exhibition visit & academic poster showcase

Strategic partnerships & collaborations

Biomanufacturing technology & development

Supply chain network management

Trends & developments for R&D in Asia

BioPharma Asia Industry Awards Dinner 2012

Wednesday, 21 March 2012: Conference Day 2

CEO Breakfast Forum

Investment opportunities for life science funds

Regulatory challenges in Asia

Vaccine development & production

Clinical supply management strategies

Promising drug discovery & development strategies in Asia

Closing Cocktail Reception

Thursday, 22 March 2012: Post conference workshops

Workshop: Positioning your company portfolio to increase deal value

Workshop: Effective clinical trial project management

Workshop: Development & production strategies for biosimilars